4.5 Article

Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Development of syringes and vials for delivery of biologics: current challenges and innovative solutions

Saki Yoneda et al.

Summary: This review discusses the challenges in developing dosage forms to improve pharmaceutical stability and how to overcome them. Expert opinions suggest that silicone oil-free syringes are preferred to minimize subvisible particles in the drug. Materials with low protein adsorption properties are recommended to prevent protein aggregation, and minimizing adverse effects of biopharmaceuticals requires proper quality control of the drug in its container, based on understanding the physicochemical stability of the protein in solution, the properties of the container, and their combinations.

EXPERT OPINION ON DRUG DELIVERY (2021)

Review Immunology

Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis

Roberto Caporali et al.

Summary: The study found that CT-P13 SC has more advantages compared to infliximab in treating patients with RA, demonstrating better efficacy and safety. Comparison with historical data also showed that CT-P13 SC has certain advantages over adalimumab/etanercept in terms of safety and efficacy.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Article Chemistry, Medicinal

Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development

Danika Rodrigues et al.

Summary: Developing ultra-high concentration biotherapeutics drug products can pose challenges due to increased viscosity, processing, and stability issues. This study examines the effects of classic stabilizers and viscosity modulators at low to high protein concentrations on ultra-high protein formulations. Results show that excipients' impact on viscosity and concentratability varies between high and ultra-high protein concentrations.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Review Chemistry, Medicinal

Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements

Advait Badkar et al.

Summary: Subcutaneous (SC) delivery of biologics has traditionally been limited to small volumes, but new technologies are emerging to enable the delivery of larger amounts of drug through the SC route, overcoming challenges related to high dosage and volume.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Review Oncology

Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins

Nicole L. Jarvi et al.

Summary: The subcutaneous route of administration provides convenient delivery, but may lead to enhanced immunogenicity; unwanted antibody response can impact pharmacokinetics and efficacy of biologics; careful consideration is needed for the unique immunogenic challenges associated with subcutaneous protein administration.

BIODRUGS (2021)

Article Polymer Science

Comparison of Huggins Coefficients and Osmotic Second Virial Coefficients of Buffered Solutions of Monoclonal Antibodies

Jai A. Pathak et al.

Summary: The Huggins coefficient k(H) is a common metric for quantifying the increase in solution viscosity in macromolecular solutions, and this paper compares it to the osmotic second virial coefficient to investigate fundamental molecular interactions in model antibody solutions. The study suggests that a better understanding of protein and ion solvation by water is needed to comprehend the significance of k(H) in terms of fundamental protein-protein interactions and the development of antibody formulations.

POLYMERS (2021)

Article Pharmacology & Pharmacy

Key factors governing the reconstitution time of high concentration lyophilized protein formulations

Shreya S. Kulkarni et al.

Summary: Reconstitution time of lyophilized protein formulations is complex and dependent on various factors. Partially crystalline cakes exhibit better reconstitution characteristics, with the inclusion of crystallizable excipients proving beneficial in speeding up reconstitution.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins

Christoph Marschall et al.

Summary: This study focuses on formulating protein drug preparations as protein powder suspensions in non-aqueous vehicles for subcutaneous injections. By utilizing protein powder suspensions, high protein stability can be achieved without the need for drying or reconstitution, offering a more convenient way of medication for patients.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Review Chemistry, Medicinal

A review of formulations of commercially available antibodies

Robert G. Strickley et al.

Summary: This review examines 126 commercially available antibodies approved globally between 1986 and February 2021, including various formulations, routes of administration, and formulation components. The number of approved antibodies per year has increased significantly after 2014. Most antibody products are packaged in single-dose units, with different routes of administration and formulation components.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Pharmacology & Pharmacy

Preparation of high concentration protein powder suspensions by milling of lyophilizates

Christoph Marschall et al.

Summary: Protein powder suspensions were prepared using swing-mill and compared to cryogenic dry milling. Wet media milling resulted in increased protein aggregation, while cryogenic dry milling could reduce aggregation, but caused damage to mAb if not cooled with liquid nitrogen.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)

Article Chemistry, Medicinal

Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions

Yuhong Zeng et al.

Summary: The study demonstrates that caffeine can effectively reduce the viscosity of mAb formulations, while commonly used viscosity-reducing excipients like sodium chloride and arginine may not achieve the same effect. Furthermore, caffeine does not affect the stability or in vitro bioactivities of the formulations.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Chemistry, Medicinal

What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical Stress

Adam Dariusz Grabarek et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Chemistry, Medicinal

Assessment of the Injection Performance of a Tapered Needle for Use in Prefilled Biopharmaceutical Products

Elena Krayukhina et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Chemistry, Multidisciplinary

Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics

David S. Collins et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Medicine, Research & Experimental

Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity

Yulei Zhang et al.

MOLECULAR PHARMACEUTICS (2020)

Review Biotechnology & Applied Microbiology

Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review

Melissa Holstein et al.

BIOTECHNOLOGY AND BIOENGINEERING (2020)

Article Chemistry, Medicinal

Reconstitution Time for Highly Concentrated Lyophilized Proteins: Role of Formulation and Protein

Shreya S. Kulkarni et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Medicine, Research & Experimental

Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site

Iris Usach et al.

ADVANCES IN THERAPY (2019)

Review Biochemical Research Methods

Selecting and engineering monoclonal antibodies with drug-like specificity

Charles G. Starr et al.

CURRENT OPINION IN BIOTECHNOLOGY (2019)

Review Biochemical Research Methods

Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins

Youngbin Baek et al.

CURRENT OPINION IN BIOTECHNOLOGY (2018)

Review Biochemistry & Molecular Biology

Viscosity Control of Protein Solution by Small Solutes: A Review

Taehun Hong et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2018)

Article Pharmacology & Pharmacy

Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions

Peng Ke et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Review Pharmacology & Pharmacy

Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes

Mridula Dwivedi et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Pharmacology & Pharmacy

High-concentration protein formulations: How high is high?

Patrick Garidel et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Article Biochemistry & Molecular Biology

Prediction and Reduction of the Aggregation of Monoclonal Antibodies

Rob van der Kant et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

Review Chemistry, Medicinal

Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins

Lora Hamuro et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Article Medicine, Research & Experimental

In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions

Dheeraj S. Tomar et al.

Review Chemistry, Medicinal

Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries

Roman Mathaes et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2016)

Article Immunology

Hizentra for the treatment of primary immunodeficiency

Richard L. Wasserman

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Structure-based engineering of a monoclonal antibody for improved solubility

Sheng-Jiun Wu et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2010)

Review Biochemical Research Methods

Formulation and manufacturability of biologics

Steven J. Shire

CURRENT OPINION IN BIOTECHNOLOGY (2009)

Review Pharmacology & Pharmacy

Nature and consequences of protein-protein interactions in high protein concentration solutions

Atul Saluja et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)

Article Chemistry, Medicinal

High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics

John R. Alford et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Review Chemistry, Medicinal

Measuring and increasing protein solubility

Saul R. Trevino et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Review Chemistry, Medicinal

Challenges in the development of high protein concentration formulations

SJ Shire et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2004)

Review Chemistry, Multidisciplinary

Stabilization of proteins in dry powder formulations using supercritical fluid technology

N Jovanovic et al.

PHARMACEUTICAL RESEARCH (2004)

Article Multidisciplinary Sciences

Crystalline monoclonal antibodies for subcutaneous delivery

MX Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)